Torgunrud A, Lund-Andersen C, Davidson B, Nitschke Marcussen IK, Larsen SG, Dagenborg V, Flatmark K (2025)
High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies
Pleura Peritoneum, 11 (1), 11-18
DOI 10.1515/pp-2025-0034, PubMed 41868810

Ree AH, Bousquet PA, Visnovska T, Lüders T, Geisler BP, Wang S, Bordin DL, Nilsen HL, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Berg JP, Flatmark K, Meltzer S (2026)
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer
Br J Cancer, 134 (8), 1176-1182
DOI 10.1038/s41416-026-03357-6, PubMed 41731117

Davidson B, Stričak LM, Holth A, Torgunrud A, Wohlschlaeger J, Tötsch M, Bassarova A (2026)
The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis
Virchows Arch, 488 (3), 617-626
DOI 10.1007/s00428-026-04438-w, PubMed 41656400